Cresar H (40+12.5) Tablet Side Effects and usage

Cresar H (40+12.5) - Hydrochlorothiazide- Tablet is manufactured by Cipla Limited and the main constituent generic drug is Hydrochlorothiazide- 12.5 mg.

Cresar H (40+12.5) Tablet Medicine Details

Side Effects

Reduced glucose tolerance, hyperuricaemia, hypokalaemia.
Electrolyte imbalance, impotence, anorexia, gastric irritation, nausea, vomiting, constipation.
Hypersensitivity reactions.


Hypertension, heart failure, mild to moderate renal or hepatic failure.
Renal diabetes insipidus.

Contra Indications

Anuria, severe renal and hepatic failure, hypersensitivity, refractory hypokalaemia and hyponatraemia, hypercalaemia and symptomatic hyperuricaemia.
Sulphonamide allergy.
Pregnancy and lactation.


Nervousness, muscle spasms, cardiac arrhythmias, electrolyte imbalance, diabetes mellitus.


The cost of the drug per 1 Tablet is Rs.7.1 in India as of date.


Cresar H (40+12.5) Tablet mainly contains the generic formulation called as Hydrochlorothiazide- 12.5 mg.

Medicine Name: Cresar H (40+12.5) Tablet
Manufacturer: Cipla Limited
Generic Molecule: Hydrochlorothiazide

Cresar H (40+12.5) Tablet Similar Medicines List:

Creso 100 Ml Syrup
Cresp 25 Mcg Injection
Cresp 40 Mcg Injection
Cresp Pfs 25 Mcg Injection
Cresp Pfs 40 Mcg Injection